Interim data for CBAY... "After sharing preliminar
Post# of 72440
(Total Views: 152)
Posted On: 09/12/2017 11:46:52 AM
Interim data for CBAY... "After sharing preliminary results from the study, the FDA has agreed to allow continuation of seladelpar treatment beyond six months for the 5 mg and 10 mg doses."
Keep this in mind when we see our interim data for prurisol.
https://finance.yahoo.com/news/cymabay-announ...00760.html
Keep this in mind when we see our interim data for prurisol.
https://finance.yahoo.com/news/cymabay-announ...00760.html
(0)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼